Similar outcomes were observed in another cross-sectional study, whereby T1DM children and adolescents receiving insulin treatment had higher levels of DKK1 and sclerostin but a lower Z-score than the controls [26]. This evidence concerns the gene DKK1 and type 1 diabetes mellitus.